Cross-manager
Summary
Quarter-aligned featured master book: the same report period across the set, then the prior quarter.
134 of 137 filed constant set 133 2024 Q2 → 2024 Q3 equal-weight holdings as of 30 Sep 2024 as of today
2024 Q3
134 of 137 filedsectors · equal-weight · 134 of 137 filed · constant set 133
?
Pie is 100% of mapped names. The hole is mapped share of full AUM. Unmapped names stay blank, never Other. mapped + unmapped ≤ 100 — options sit in the denominator. pie is that mapped slice, not the book.
Waterfall reads left to right: start, each sector’s Δ, then the end. Green is up, red is down. Equal-weight is mix-shift of the mapped pie; dollar-sum is mapped dollars. axis zoomed to the move.
Grid is each manager’s latest 13F (mixed dates). Long equity only. Dollars across the constant set.
1 new in 2024 Q3 — excluded from Δ: Rule One Partners.
| sector | 2024 Q2 | 2024 Q3 | Δ |
|---|---|---|---|
| Communication Services | 9.5% | 9.1% | −0.41% |
| Consumer Discretionary | 16.9% | 17.3% | +0.42% |
| Consumer Staples | 2.7% | 2.7% | −0.05% |
| Energy | 4.6% | 4.2% | −0.34% |
| Financials | 17.7% | 17.7% | −0.04% |
| Health Care | 11.9% | 12.6% | +0.66% |
| Industrials | 9.9% | 9.9% | +0.00% |
| Information Technology | 20.9% | 20.1% | −0.72% |
| Materials | 1.9% | 2.1% | +0.23% |
| Real Estate | 2.5% | 2.7% | +0.15% |
| Utilities | 1.5% | 1.6% | +0.10% |
Health Care · 329 shown · 134 of 137 filed · equal-weight
?
Share-count breadth; splits look like Adds. Direction is Δ equal-weight. Dollars across the constant set.
| ticker | issuer | owners | eq | usd | Δ | new | add | reduce | exit |
|---|---|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group Inc. |
27 |
0.54% | 0.79% | +0.01% | 2 | 8 | 15 | 4 |
| ELV | Elevance Health Inc. |
12 |
0.33% | 0.39% | −0.05% | 0 | 5 | 5 | 2 |
| CVS | Cvs Health Corp. |
14 |
0.32% | 0.45% | +0.07% | 1 | 8 | 5 | 1 |
| HCA | Hca Healthcare Inc. |
11 |
0.26% | 0.53% | +0.03% | 1 | 3 | 5 | 1 |
| SGRY | Surgery Partners Inc. | 0.25% | <0.01% | +0.24% | 1 | 0 | 3 | 1 | |
| DHR | Danaher Corporation |
16 |
0.24% | 0.10% | +0.02% | 1 | 2 | 8 | 1 |
| HROW | Harrow Health Inc. | 0.22% | 0.01% | +0.08% | 0 | 0 | 0 | 0 | |
| UTHR | United Therapeutics Corp. | 0.22% | <0.01% | −0.00% | 0 | 0 | 3 | 2 | |
| MDGL | Madrigal Pharmaceuticals Inc. | 0.21% | 0.03% | −0.08% | 0 | 1 | 0 | 0 | |
| NTRA | Natera Inc. | 0.20% | 0.10% | +0.08% | 0 | 5 | 2 | 1 | |
| JNJ | Johnson & Johnson |
16 |
0.19% | 0.08% | +0.04% | 1 | 4 | 5 | 0 |
| NVAX | Novavax Inc. | 0.18% | 0.01% | −0.02% | 0 | 1 | 2 | 0 | |
| CI | The Cigna Group | 0.18% | 0.51% | −0.03% | 0 | 4 | 5 | 2 | |
| TMO | Thermo Fisher Scientific Inc. |
15 |
0.18% | 0.22% | −0.00% | 1 | 3 | 11 | 0 |
| MCK | Mckesson Corp. | 0.18% | 0.03% | −0.05% | 0 | 2 | 1 | 3 | |
| BIIB | Biogen Inc. | 0.17% | <0.01% | −0.03% | 0 | 0 | 5 | 0 | |
| AVAH | Aveanna Healthcare Hldgs Inc. | 0.17% | <0.01% | +0.10% | 0 | 0 | 0 | 0 | |
| GEHC | Ge Healthcare Technologies, Inc. | 0.17% | 0.19% | +0.04% | 1 | 2 | 5 | 1 | |
| EXEL | Exelixis Inc. | 0.16% | 0.05% | +0.01% | 0 | 1 | 2 | 0 | |
| INSM | Insmed Inc. | 0.16% | 0.02% | +0.02% | 1 | 2 | 2 | 1 | |
| THC | Tenet Healthcare Corp. | 0.14% | 0.05% | −0.05% | 0 | 2 | 5 | 0 | |
| SOLV | Solventum Corporation | 0.14% | 0.07% | +0.05% | 0 | 2 | 2 | 1 | |
| MRK | Merck & Co. Inc. |
13 |
0.14% | 0.04% | −0.02% | 1 | 2 | 6 | 3 |
| BHC | Bausch Health Companies Inc. | 0.14% | 0.04% | +0.02% | 0 | 1 | 0 | 1 | |
| ILMN | Illumina Inc. | 0.14% | 0.04% | +0.01% | 1 | 1 | 5 | 0 | |
| BMY | Bristol-Myers Squibb Co. |
12 |
0.13% | 0.12% | +0.03% | 1 | 5 | 5 | 0 |
| JAZZ | Jazz Pharmaceuticals PLC | 0.13% | <0.01% | −0.03% | 0 | 1 | 2 | 1 | |
| CAH | Cardinal Health Inc. | 0.13% | 0.02% | +0.02% | 0 | 1 | 3 | 1 | |
| OSCR | Oscar Health Inc. | 0.12% | 0.03% | +0.01% | 1 | 1 | 2 | 0 | |
| PFE | Pfizer Inc. |
11 |
0.12% | 0.03% | −0.02% | 0 | 4 | 6 | 1 |
| BMRN | Biomarin Pharmaceutical, Inc. | 0.12% | 0.14% | −0.00% | 1 | 1 | 2 | 2 | |
| TRUP | Trupanion Inc. | 0.10% | <0.01% | +0.04% | 0 | 1 | 1 | 0 | |
| MDT | Medtronic PLC |
10 |
0.10% | 0.19% | −0.00% | 0 | 5 | 5 | 0 |
| VTRS | Viatris Inc. | 0.10% | 0.06% | +0.00% | 1 | 2 | 2 | 0 | |
| SYK | Stryker Corp. | 0.10% | 0.18% | +0.00% | 0 | 1 | 2 | 0 | |
| ZTS | Zoetis Inc. | 0.10% | 0.16% | +0.01% | 1 | 2 | 4 | 0 | |
| LLY | Eli Lilly & Co. |
12 |
0.10% | 0.14% | +0.01% | 2 | 5 | 5 | 0 |
| HUM | Humana, Inc. | 0.10% | 0.25% | −0.06% | 1 | 4 | 2 | 4 | |
| BLCO | Bausch Plus Lomb Corp. | 0.09% | <0.01% | +0.08% | 1 | 0 | 1 | 0 | |
| IQV | Iqvia Hldgs Inc. | 0.08% | 0.25% | −0.00% | 0 | 1 | 3 | 1 | |
| BAX | Baxter International, Inc. | 0.08% | 0.23% | +0.01% | 0 | 4 | 3 | 0 | |
| RVMD | Revolution Medicines Inc. | 0.07% | 0.04% | +0.02% | 0 | 3 | 0 | 1 | |
| WST | East West Bancorp Inc. | 0.07% | 0.02% | +0.01% | 0 | 0 | 0 | 0 | |
| OGN | Organon & Company | 0.07% | <0.01% | +0.00% | 0 | 2 | 0 | 0 | |
| SNY | Sanofi SA | 0.07% | 0.32% | +0.02% | 1 | 3 | 3 | 1 | |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.07% | 0.14% | +0.01% | 0 | 4 | 4 | 0 | |
| WAT | Waters Corp. | 0.07% | 0.11% | +0.01% | 0 | 0 | 3 | 0 | |
| BSX | Boston Scientific Corp. | 0.07% | 0.05% | +0.01% | 1 | 3 | 3 | 0 | |
| TGTX | Tg Therapeutics Inc. | 0.07% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| ENTA | Enanta Pharmaceuticals Inc. | 0.07% | <0.01% | +0.01% | 0 | 2 | 0 | 0 | |
| TEVA | Teva Pharmaceutical Inds Ltd | 0.06% | 0.03% | +0.00% | 2 | 1 | 3 | 1 | |
| ALC | Alcon Inc. | 0.06% | 0.04% | +0.00% | 1 | 0 | 1 | 0 | |
| SHC | Sotera Health Co. | 0.06% | 0.01% | +0.00% | 0 | 1 | 0 | 2 | |
| IDXX | Idexx Laboratories Inc. | 0.06% | 0.16% | −0.00% | 0 | 2 | 1 | 0 | |
| A | Agilent Technologies Inc. | 0.06% | 0.06% | −0.02% | 0 | 0 | 4 | 1 | |
| CNC | Centene Corp. Del | 0.06% | 0.16% | −0.02% | 0 | 1 | 3 | 1 | |
| WST | Western Alliance Bancorp | 0.06% | <0.01% | +0.01% | 1 | 0 | 2 | 0 | |
| BNTX | Biontech Se | 0.06% | <0.01% | +0.02% | 4 | 1 | 1 | 0 | |
| CRL | Charles Riv Labs Intl Inc. | 0.06% | 0.03% | −0.01% | 0 | 1 | 4 | 0 | |
| RPRX | Royalty Pharma PLC | 0.06% | 0.03% | +0.01% | 0 | 4 | 0 | 0 | |
| GSK | Gsk PLC | 0.06% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| FTRE | Fortrea Hldgs Inc. | 0.06% | 0.02% | +0.00% | 2 | 2 | 1 | 1 | |
| OCUL | Ocular Therapeutix Inc. | 0.05% | <0.01% | −0.01% | 0 | 0 | 1 | 0 | |
| IONS | Ionis Pharmaceuticals Inc. | 0.05% | 0.01% | −0.01% | 0 | 1 | 1 | 2 | |
| ARVN | Arvinas Inc. | 0.05% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| STXS | Stereotaxis Inc. | 0.05% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ABT | Abbott Labs | 0.05% | 0.13% | +0.00% | 1 | 0 | 4 | 0 | |
| BDX | Becton Dickinson & Co. | 0.05% | 0.06% | +0.01% | 0 | 4 | 1 | 0 | |
| EW | Edwards Lifesciences Corp. | 0.05% | <0.01% | −0.00% | 4 | 2 | 1 | 0 | |
| ALKS | Alkermes PLC | 0.05% | <0.01% | +0.01% | 0 | 0 | 3 | 0 | |
| ISRG | Intuitive Surgical Inc. | 0.05% | 0.05% | −0.01% | 0 | 2 | 2 | 2 | |
| CYTK | Cytokinetics Inc. | 0.04% | <0.01% | −0.02% | 0 | 1 | 1 | 1 | |
| NVO | Novo-Nordisk A S | 0.04% | 0.09% | −0.02% | 0 | 2 | 3 | 2 | |
| SNDX | Syndax Pharmaceuticals Inc. | 0.04% | <0.01% | −0.01% | 0 | 0 | 2 | 0 | |
| UHS | Universal Hlth Svcs Inc. | 0.04% | 0.09% | −0.01% | 1 | 1 | 2 | 1 | |
| IDYA | Ideaya Biosciences Inc. | 0.04% | <0.01% | +0.00% | 0 | 2 | 0 | 0 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.04% | 0.07% | +0.02% | 1 | 0 | 2 | 1 | |
| GSK | Gsk PLC | 0.04% | 0.20% | +0.00% | 0 | 3 | 2 | 0 | |
| ASND | Ascendis Pharma A/S | 0.04% | <0.01% | +0.02% | 3 | 1 | 0 | 1 | |
| INDV | Indivior PLC | 0.04% | <0.01% | +0.03% | 1 | 1 | 0 | 0 | |
| ACHC | Acadia Healthcare Company In | 0.04% | 0.03% | −0.00% | 0 | 2 | 2 | 0 | |
| ACAD | Acadia Pharmaceuticals Inc. | 0.04% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| MTD | Mettler Toledo Ord | 0.04% | 0.09% | +0.00% | 0 | 1 | 2 | 0 | |
| NBIX | Neurocrine Biosciences, Inc. | 0.04% | 0.02% | −0.01% | 0 | 1 | 3 | 0 | |
| DGX | Quest Diagnostics Inc. | 0.04% | 0.03% | −0.00% | 0 | 3 | 3 | 0 | |
| ROIV | Roivant Sciences Ltd | 0.04% | 0.05% | −0.00% | 0 | 1 | 2 | 0 | |
| LFCR | Lifecore Biomedical Inc. | 0.04% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| RYTM | Rhythm Pharmaceuticals Inc. | 0.03% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| ABBV | Abbvie Inc. |
10 |
0.03% | 0.01% | −0.01% | 0 | 3 | 4 | 1 |
| NVST | Envista Holdings Corporation | 0.03% | 0.03% | +0.01% | 0 | 1 | 2 | 0 | |
| BHVN | Biohaven Ltd | 0.03% | 0.02% | +0.01% | 0 | 3 | 1 | 0 | |
| ATRC | Atricure Inc. | 0.03% | <0.01% | +0.01% | 0 | 1 | 0 | 0 | |
| XENE | Xenon Pharmaceuticals Inc. | 0.03% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| WGS | Genedx Holdings Corp. | 0.03% | <0.01% | +0.01% | 0 | 0 | 0 | 0 | |
| DNTH | Dianthus Therapeutics Inc. | 0.03% | <0.01% | +0.01% | 0 | 0 | 0 | 0 | |
| PCVX | Vaxcyte Inc. | 0.03% | <0.01% | +0.00% | 2 | 1 | 1 | 1 | |
| EWTX | Edgewise Therapeutics Inc. | 0.03% | <0.01% | +0.00% | 0 | 0 | 2 | 0 | |
| PRTA | Prothena Corp. PLC | 0.03% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| IOVA | Iovance Biotherapeutics Inc. | 0.03% | <0.01% | +0.00% | 0 | 1 | 0 | 1 | |
| ANAB | Anaptysbio Inc. | 0.03% | <0.01% | +0.01% | 1 | 1 | 0 | 0 | |
| LH | Labcorp Holdings Inc. | 0.03% | 0.01% | −0.00% | 0 | 1 | 2 | 0 | |
| WRBY | Warby Parker Inc. | 0.03% | 0.02% | −0.00% | 0 | 2 | 2 | 1 | |
| GILD | Gilead Sciences, Inc. | 0.03% | 0.20% | −0.00% | 0 | 0 | 4 | 1 | |
| VEEV | Veeva Sys Inc. | 0.03% | 0.03% | +0.00% | 0 | 2 | 3 | 2 | |
| MEDP | Medpace Holdings Inc. | 0.02% | <0.01% | −0.00% | 0 | 3 | 1 | 0 | |
| ICLR | Icon PLC | 0.02% | 0.05% | −0.00% | 0 | 1 | 3 | 0 | |
| CRSP | Crispr Therapeutics AG | 0.02% | 0.02% | −0.00% | 0 | 0 | 2 | 1 | |
| TECH | Bio Techne Corp. | 0.02% | 0.04% | +0.00% | 0 | 2 | 3 | 0 | |
| CGON | Cg Oncology Inc. | 0.02% | <0.01% | +0.01% | 0 | 1 | 0 | 0 | |
| AXGN | Axogen Inc. | 0.02% | <0.01% | +0.01% | 0 | 0 | 0 | 0 | |
| CATX | Perspective Therapeutics Inc. | 0.02% | <0.01% | +0.01% | 0 | 1 | 1 | 0 | |
| VRTX | Vertex Pharmaceuticals Inc. | 0.02% | <0.01% | +0.00% | 1 | 1 | 2 | 0 | |
| INCY | Incyte Corp. | 0.02% | 0.08% | +0.01% | 1 | 0 | 3 | 0 | |
| LQDA | Liquidia Corporation | 0.02% | <0.01% | +0.01% | 0 | 2 | 0 | 0 | |
| IART | Integra Lifesciences Hldgs C | 0.02% | <0.01% | +0.02% | 1 | 1 | 0 | 0 | |
| ETON | Eton Pharmaceuticals Inc. | 0.02% | <0.01% | +0.01% | 0 | 1 | 0 | 0 | |
| WST | West Pharmaceutical Svsc Inc. | 0.02% | 0.03% | −0.01% | 0 | 1 | 1 | 0 | |
| DVA | Davita Inc. | 0.02% | 0.42% | +0.00% | 0 | 1 | 1 | 1 | |
| MOH | Molina Healthcare Inc. | 0.02% | 0.03% | +0.01% | 0 | 1 | 0 | 1 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.02% | 0.18% | −0.04% | 2 | 0 | 5 | 1 | |
| AMGN | Amgen Inc. | 0.02% | <0.01% | −0.00% | 0 | 3 | 5 | 0 | |
| DYN | Dyne Therapeutics Inc. | 0.02% | <0.01% | +0.00% | 1 | 1 | 0 | 0 | |
| BBIO | Bridgebio Pharma Inc. | 0.02% | 0.05% | +0.00% | 1 | 0 | 0 | 0 | |
| PBH | Prestige Consmr Healthcare I | 0.02% | 0.01% | −0.00% | 0 | 1 | 2 | 0 | |
| BEAM | Beam Therapeutics Inc. | 0.02% | 0.03% | −0.00% | 0 | 1 | 2 | 0 | |
| RCKT | Rocket Pharmaceuticals Inc. | 0.02% | <0.01% | −0.00% | 0 | 2 | 2 | 0 | |
| NAMS | Newamsterdam Pharma Company | 0.02% | 0.01% | −0.00% | 1 | 2 | 0 | 0 | |
| GKOS | Glaukos Corp. | 0.02% | <0.01% | +0.01% | 0 | 1 | 0 | 0 | |
| RARE | Ultragenyx Pharmaceutical In | 0.02% | <0.01% | +0.00% | 2 | 0 | 2 | 0 | |
| TWST | Twist Bioscience Corp. | 0.02% | 0.02% | −0.00% | 0 | 1 | 1 | 0 | |
| URGN | Urogen Pharma Ltd | 0.02% | <0.01% | −0.01% | 0 | 0 | 3 | 0 | |
| VKTX | Viking Therapeutics Inc. | 0.02% | <0.01% | −0.00% | 0 | 0 | 3 | 0 | |
| PRVA | Privia Health Group Inc. | 0.02% | 0.02% | −0.00% | 0 | 2 | 1 | 1 | |
| PTGX | Protagonist Therapeutics Inc. | 0.02% | 0.02% | +0.00% | 0 | 1 | 0 | 0 | |
| NRIX | Nurix Therapeutics Inc. | 0.02% | <0.01% | −0.00% | 0 | 1 | 1 | 1 | |
| TNDM | Tandem Diabetes Care Inc. | 0.02% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| RXRX | Recursion Pharmaceuticals Inc. | 0.01% | 0.02% | +0.00% | 0 | 1 | 0 | 0 | |
| DXCM | Dexcom Inc. | 0.01% | <0.01% | −0.02% | 0 | 0 | 2 | 3 | |
| KURA | Kura Oncology Inc. | 0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| LNTH | Lantheus Hldgs Inc. | 0.01% | 0.02% | −0.00% | 0 | 1 | 1 | 1 | |
| MIRM | Mirum Pharmaceuticals Inc. | 0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| HSIC | Henry Schein Inc. | 0.01% | <0.01% | +0.00% | 2 | 1 | 1 | 0 | |
| PHAT | Phathom Pharmaceuticals Inc. | 0.01% | <0.01% | +0.01% | 0 | 1 | 0 | 0 | |
| NVS | Novartis AG | 0.01% | 0.10% | −0.00% | 0 | 1 | 3 | 1 | |
| VCYT | Veracyte Inc. | 0.01% | 0.01% | +0.00% | 0 | 0 | 1 | 1 | |
| WVE | Wave Life Sciences Ltd | 0.01% | <0.01% | +0.01% | 0 | 1 | 0 | 1 | |
| ALGN | Align Technology Inc. | 0.01% | <0.01% | +0.00% | 0 | 3 | 1 | 0 | |
| AXSM | Axsome Therapeutics Inc. | 0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| TRVI | Trevi Therapeutics Inc. | 0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| LKFT | Galapagos NV | 0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| QDEL | Quidelortho Corp. | 0.01% | <0.01% | −0.01% | 0 | 0 | 1 | 1 | |
| ARGX | Argenx Se | 0.01% | 0.01% | −0.00% | 0 | 0 | 2 | 0 | |
| LIVN | Livanova PLC | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| GPCR | Structure Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 1 | 1 | |
| DNA | Ginkgo Bioworks Holdings Inc. | <0.01% | <0.01% | +0.01% | 3 | 0 | 0 | 0 | |
| NVCR | Novocure Ltd | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| AGIO | Agios Pharmaceuticals Inc. | <0.01% | 0.02% | +0.00% | 0 | 1 | 0 | 0 | |
| NMRA | Neumora Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| KYMR | Kymera Therapeutics Inc. | <0.01% | <0.01% | +0.01% | 2 | 0 | 0 | 0 | |
| BCRX | Biocryst Pharmaceuticals Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| FMS | Fresenius Medical Care AG | <0.01% | 0.03% | +0.00% | 0 | 1 | 1 | 0 | |
| COLL | Collegium Pharmaceutical Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 2 | |
| ADPT | Adaptive Biotechnologies Cor | <0.01% | 0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| VNDA | Vanda Pharmaceuticals Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 2 | 0 | |
| CDNA | Caredx Inc. | <0.01% | 0.01% | +0.00% | 0 | 0 | 2 | 0 | |
| PHG | Koninklijke Philips NV | <0.01% | <0.01% | +0.00% | 0 | 0 | 2 | 0 | |
| ALEC | Alector Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ORKA | Oruka Therapeutics Inc. | <0.01% | <0.01% | +0.01% | 1 | 0 | 0 | 0 | |
| NGNE | Neurogene Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 2 | 0 | |
| BCYC | Bicycle Therapeutics PLC | <0.01% | <0.01% | +0.00% | 1 | 0 | 1 | 0 | |
| LXEO | Lexeo Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| SUPN | Supernus Pharmaceuticals, Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| RCUS | Arcus Biosciences Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ORIC | Oric Pharmaceuticals Inc. | <0.01% | <0.01% | +0.01% | 1 | 0 | 0 | 1 | |
| PODD | Insulet Corp. | <0.01% | <0.01% | −0.01% | 0 | 0 | 0 | 1 | |
| PGEN | Precigen Inc. | <0.01% | <0.01% | −0.01% | 0 | 0 | 1 | 0 | |
| XRAY | Dentsply Sirona Inc. | <0.01% | 0.03% | +0.00% | 0 | 2 | 0 | 0 | |
| ULS | Ul Solutions Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 2 | |
| STOK | Stoke Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| COO | Cooper Cos Inc. | <0.01% | <0.01% | +0.00% | 1 | 1 | 1 | 0 | |
| TFX | Teleflex Incorporated | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ELAN | Elanco Animal Health, Inc. | <0.01% | 0.09% | +0.00% | 1 | 1 | 1 | 0 | |
| SPRY | Ars Pharmaceuticals Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 1 | 0 | |
| LRMR | Larimar Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| MRNA | Moderna Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 1 | 1 | |
| BTI | British Amern Tob PLC | <0.01% | <0.01% | +0.00% | 0 | 2 | 0 | 0 | |
| CNTX | Context Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| IMVT | Immunovant Inc. | <0.01% | <0.01% | −0.01% | 0 | 1 | 2 | 1 | |
| ALLO | Allogene Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| AQST | Aquestive Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| IPSC | Century Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| SDGR | Schrodinger Inc. | <0.01% | 0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| MYGN | Myriad Genetics Inc. | <0.01% | <0.01% | −0.01% | 0 | 0 | 1 | 0 | |
| ITGR | Integer Hldgs Corp. | <0.01% | 0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| ZNTL | Zentalis Pharmaceuticals Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| OPCH | Option Care Health Inc. | <0.01% | <0.01% | −0.01% | 1 | 1 | 1 | 1 | |
| RLMD | Relmada Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| COGT | Cogent Biosciences Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| BWAY | Brainsway Ltd | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| LFST | Lifestance Health Group Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 1 | 0 | |
| ARAY | Accuray Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| ALVO | Alvotech SA | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| BFLY | Butterfly Network Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| INGN | Inogen Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| CMPS | Compass Pathways PLC | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| ALHC | Alignment Healthcare Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| TAK | Takeda Pharmaceutical Co. Ltd | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| ARCT | Arcturus Therapeutics Holdings | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| HALO | Halozyme Therapeutics | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ESTA | Establishment Labs Hldgs Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 1 | 0 | |
| RMD | Resmed Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| MLYS | Mineralys Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| AUTL | Autolus Therapeutics PLC | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| NEOG | Neogen Corp. | <0.01% | <0.01% | +0.00% | 0 | 2 | 0 | 0 | |
| PRQR | Proqr Therapeutics N V | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| RZLT | Rezolute Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| EMBC | Embecta Corp. | <0.01% | <0.01% | +0.00% | 0 | 0 | 2 | 0 | |
| NUVB | Nuvation Bio Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| CGEM | Cullinan Therapeutics Inc. | <0.01% | <0.01% | −0.01% | 0 | 0 | 1 | 0 | |
| PRME | Prime Medicine Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| PSNL | Personalis Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ABCL | Abcellera Biologics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| WST | West Fraser Timber Ltd | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| BKD | Brookdale Sr Living Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 1 | 0 | |
| COYA | Coya Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| GH | Guardant Health Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| INSP | Inspire Med Sys Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 2 | 0 | |
| PEPG | Pepgen Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| ZLAB | Zai Lab Ltd | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| CERS | Cerus Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| DMAC | Diamedica Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| COR | Cencora Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 1 | |
| EDIT | Editas Medicine Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| TMDX | Transmedics Group Inc. | <0.01% | <0.01% | +0.00% | 1 | 1 | 0 | 0 | |
| IVVD | Invivyd Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| PHVS | Pharvaris N V | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| ABSI | Absci Corp. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ANRO | Alto Neuroscience Inc. | <0.01% | <0.01% | −0.00% | 1 | 0 | 1 | 0 | |
| TSHA | Taysha Gene Therapies Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| RDY | Dr Reddy's Laboratories Ltd | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| GUTS | Fractyl Health Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| TVTX | Travere Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| EOLS | Evolus Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| HIMS | Hims & Hers Health Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| SRTA | Blade Air Mobility Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| ACRV | Acrivon Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| QURE | Uniqure NV | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| GRAL | Grail Inc. | <0.01% | <0.01% | −0.00% | 1 | 0 | 1 | 2 | |
| ALDX | Aldeyra Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ADCT | Adc Therapeutics SA | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| OSUR | Orasure Technologies Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| IBIO | Ibio Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| BDTX | Black Diamond Therapeutics I | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| USNA | Usana Health Sciences Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| ARDT | Ardent Health Partners Inc. | <0.01% | <0.01% | +0.00% | 2 | 0 | 0 | 0 | |
| INBX | Inhibrx Biosciences Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| GRFS | Grifols S A | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| PGNY | Progyny Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 1 | 0 | |
| VSTM | Verastem Inc. | <0.01% | <0.01% | −0.00% | 1 | 0 | 0 | 1 | |
| RFL | Rafael Holding | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| APRE | Aprea Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| ACRS | Aclaris Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| FHTX | Foghorn Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| PYXS | Pyxis Oncology Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| CON | Concentra Group Holdings Par | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| RGEN | Repligen Corp. | <0.01% | <0.01% | +0.00% | 0 | 1 | 1 | 0 | |
| TECX | Tectonic Therapeutic Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| EHC | Encompass Health Corp. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| ENOV | Enovis Corporation | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| VYGR | Voyager Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| CRMD | Cormedix Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| SYRE | Spyre Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 2 | |
| WST | Western Midstream Partners L | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| CMPX | Compass Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ADGM | Adagio Med Hldgs Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| MRVI | Maravai Lifesciences Hldgs I | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| XERS | Xeris Biopharma Holdings Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| GANX | Gain Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| SNN | Smith & Nephew PLC | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| AORT | Artivion Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| BIOA | Bioage Labs Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| PNTG | Pennant Group Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 1 | 0 | |
| CRBU | Caribou Biosciences Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| AHCO | Adapthealth Corp. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 1 | |
| RDNT | Radnet Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| MBX | Mbx Biosciences Inc. | <0.01% | <0.01% | +0.00% | 2 | 0 | 0 | 0 | |
| AMLX | Amylyx Pharmaceuticals Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| BCAX | Bicara Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 2 | 0 | 0 | 0 | |
| EYE | National Vision Hldgs Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| CVRX | Cvrx Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| APYX | Apyx Med Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| ABEO | Abeona Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| VCEL | Vericel Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| INFU | Infusystem Hldgs Inc. | <0.01% | <0.01% | −0.00% | 0 | 1 | 0 | 0 | |
| ZBIO | Zenas Biopharma Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| ANGO | Angiodynamics Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ATEC | Alphatec Hldgs Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| GMAB | Genmab A/S | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| MSA | Msa Safety Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| REPL | Replimune Group Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| GALT | Galectin Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| KRYS | Krystal Biotech Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| VMD | Viemed Healthcare Inc. | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| BTSG | Brightspring Health Svcs Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| LTRN | Lantern Pharma Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| MMSI | Merit Med Sys Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| GMED | Globus Med Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ONC | Beigene Ltd | <0.01% | <0.01% | +0.00% | 1 | 0 | 0 | 0 | |
| ARQT | Arcutis Biotherapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| CHE | Chemed Corp. New | <0.01% | <0.01% | −0.02% | 0 | 0 | 0 | 1 | |
| GERN | Geron Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 1 | 0 | |
| ENSG | Ensign Group Inc. | <0.01% | <0.01% | +0.00% | 0 | 1 | 0 | 0 | |
| ALT | Altimmune Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| CCCC | C4 Therapeutics Inc. | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ARDX | Ardelyx Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| CGC | Canopy Growth Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 0 | |
| IRWD | Ironwood Pharmaceuticals Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| CYH | Community Health Sys Inc. New | <0.01% | <0.01% | +0.00% | 0 | 0 | 0 | 0 | |
| ANIP | Ani Pharmaceuticals Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| ALNY | Alnylam Pharmaceuticals Inc. | <0.01% | <0.01% | −0.04% | 0 | 0 | 0 | 1 | |
| CRBP | Corbus Pharmaceuticals Hldgs | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| DSGN | Design Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| DCGO | Docgo Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| FDMT | 4D Molecular Therapeutics In | <0.01% | <0.01% | −0.01% | 0 | 0 | 0 | 2 | |
| FULC | Fulcrum Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| IRTC | Irhythm Technologies Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| PRCT | Procept Biorobotics Corp. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 | |
| RAPP | Rapport Therapeutics Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 2 | |
| TYRA | Tyra Biosciences Inc. | <0.01% | <0.01% | −0.00% | 0 | 0 | 0 | 1 |